81 related articles for article (PubMed ID: 33608484)
1. A clinical score for neuroendocrine tumor patients under consideration for Lu-177-DOTATATE therapy.
Das S; Du L; Schad A; Jain S; Jessop A; Shah C; Eisner D; Cardin D; Ciombor K; Goff L; Bradshaw M; Delbeke D; Sandler M; Berlin J
Endocr Relat Cancer; 2021 Mar; 28(3):203-212. PubMed ID: 33608484
[TBL] [Abstract][Full Text] [Related]
2. p53 stabilisation potentiates [
Berglund H; Salomonsson SL; Mohajershojai T; Gago FJF; Lane DP; Nestor M
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):768-778. PubMed ID: 37823909
[TBL] [Abstract][Full Text] [Related]
3. The radiosensitizer Onalespib increases complete remission in
Lundsten S; Spiegelberg D; Raval NR; Nestor M
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):980-990. PubMed ID: 31912256
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcomes of [
Iqbal S; Zhuang E; Raj M; Bahary N; Monga DK
Front Oncol; 2024; 14():1393317. PubMed ID: 38817893
[TBL] [Abstract][Full Text] [Related]
5. Dosing lutetium Lu 177-dotatate for a hemodialysis patient.
Taylor L; Meades R; Quigley AM; Toumpanakis C; Goodlad C; Davenport A
Hemodial Int; 2024 Apr; 28(2):247-252. PubMed ID: 38448766
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma.
Kurz SC; Zan E; Cordova C; Troxel AB; Barbaro M; Silverman JS; Snuderl M; Zagzag D; Kondziolka D; Golfinos JG; Chi AS; Sulman EP
Clin Cancer Res; 2024 Feb; 30(4):680-686. PubMed ID: 38048045
[TBL] [Abstract][Full Text] [Related]
7. Acute Disseminated Intravascular Coagulation Precipitated by
Fiocco C; Farooq F; Kaveney A
J Gastrointest Cancer; 2023 Dec; 54(4):1370-1372. PubMed ID: 36795338
[No Abstract] [Full Text] [Related]
8. Successful Combination of Olaparib and
Kröcher A; Folprecht G; Winzer R; Sergon M; Bornhäuser M; Kotzerke J; Brogsitter C
Case Rep Oncol; 2023; 16(1):1166-1171. PubMed ID: 37900794
[TBL] [Abstract][Full Text] [Related]
9. Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response.
Yang Y; Vedvyas Y; Alcaina Y; Son JY; Min IM; Jin MM
Front Immunol; 2024; 15():1355388. PubMed ID: 38550578
[TBL] [Abstract][Full Text] [Related]
10. Remarkable regression of inoperable pancreatic grade 3 neuroendocrine neoplasm after radioligand therapy with [177Lu]Lu-DOTATATE and [90Y]Y‑DOTATATE.
Durma AD; Saracyn M; Kołodziej M; Jóźwik-Plebanek K; Kamiński G
Pol Arch Intern Med; 2023 Nov; 133(11):. PubMed ID: 37795839
[No Abstract] [Full Text] [Related]
11. Spectrum of therapy-related clonal cytopenias and neoplasms after exposure to Lutetium-177-Dotatate.
Pritzl SL; Kusne Y; Halfdanarson TR; Hobday T; Sonbol MB; Kendi AT; Mangaonkar AA; Gangat N; Shah M; Patnaik MM
Leuk Res; 2024 Jan; 136():107434. PubMed ID: 38154192
[No Abstract] [Full Text] [Related]
12.
Strosberg J
Oncotarget; 2018 Sep; 9(69):33059. PubMed ID: 30237849
[No Abstract] [Full Text] [Related]
13. 177 Lu-DOTATATE in the Treatment of Recurrent Pheochromocytoma With Multiple Metastases.
Su D; Zhang Y; Li Z; Yang H; Chen Y
Clin Nucl Med; 2024 Apr; 49(4):338-339. PubMed ID: 38049973
[TBL] [Abstract][Full Text] [Related]
14. Twelve Cs for getting health systems to net zero.
Smith R
BMJ; 2023 Oct; 383():2366. PubMed ID: 37827577
[No Abstract] [Full Text] [Related]
15. Efficacy of multimodal anticancer therapy in the course of pancreatic neuroendocrine carcinoma.
Zwinczewska H; Opalinska M; Sowa-Staszczak A; Kurzynska A; Stefanska A; Hubalewska-Dydejczyk A
Endokrynol Pol; 2021; 72(2):183-184. PubMed ID: 33619719
[TBL] [Abstract][Full Text] [Related]
16. Current Treatment Strategies and Future Directions for Extrapulmonary Neuroendocrine Carcinomas: A Review.
Stelwagen J; de Vries EGE; Walenkamp AME
JAMA Oncol; 2021 May; 7(5):759-770. PubMed ID: 33630040
[TBL] [Abstract][Full Text] [Related]
17. Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant
Parghane RV; Bhandare M; Chaudhari V; Ostwal V; Ramaswamy A; Talole S; Shrikhande SV; Basu S
J Nucl Med; 2021 Nov; 62(11):1558-1563. PubMed ID: 33637590
[TBL] [Abstract][Full Text] [Related]
18. 68Ga DOTATATE PET/CT imaging of Currarino syndrome with neuroendocrine tumor.
Harwood ML; Nguyen BD
Jpn J Clin Oncol; 2021 May; 51(6):1013-1014. PubMed ID: 33621319
[No Abstract] [Full Text] [Related]
19. Expression of kisspeptin and KISS1 receptor in pituitary neuroendocrine tumours - an immunohistochemical study.
Mihajlovic M; Pekic S; Doknic M; Stojanovic M; Miljic D; Soldatovic I; Vukotic T; Janev T; Cirovic S; Terzic T; Raicevic S; Skender-Gazibara M; Popovic V; Manojlovic-Gacic E
Endokrynol Pol; 2021; 72(2):91-96. PubMed ID: 33619706
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
